PGIM India Healthcare Fund Direct G
Summary Info
Fund Name
: PGIM India Mutual Fund
Scheme Name
: PGIM India Healthcare Fund Direct G
AMC
: PGIM India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 19-Nov-2024
Fund Manager
: Anandha Padmanabhan Anjen
Net Assets (Rs. cr)
: 111.64
PGIM India Healthcare Fund Direct G - Nav Details
Nav Date
: 01-Sep-2026
NAV [Rs.]
: 12.59
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL
PGIM India Healthcare Fund Direct G- NAV Chart
PGIM India Healthcare Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.88 | 2.35 | 16.03 | 22.82 | 27.17 | - | - | 14.17 |
| Category Avg | 0.63 | 2.09 | 12.23 | 18.57 | 19.13 | 21.88 | 14.59 | 17.99 |
| Category Best | 1.89 | 5.89 | 16.51 | 26.57 | 28.66 | 25.35 | 18.68 | 31.94 |
| Category Worst | -0.5 | -0.18 | 6.46 | 7.75 | 6.38 | 17.91 | 11.51 | 6.58 |
PGIM India Healthcare Fund Direct G- Latest Dividends
No Records Found
PGIM India Healthcare Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Manipal Health18,250
Out
InName Of The CompanyNo Of Shares
J B Chemicals &28,785
Dr Reddy's Labs20,021
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.86 | 60898 | 12.12 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.35 | 14339 | 11.55 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 9.38 | 20440 | 10.47 |
| Equity | Aster DM Quality | Healthcare Services | 6.21 | 84379 | 6.93 |
| Equity | Max Healthcare | Healthcare Services | 5.86 | 59564 | 6.54 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 5.20 | 16765 | 5.80 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.66 | 21045 | 5.19 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 4.05 | 23732 | 4.52 |
| Equity | Krishna Institu. | Healthcare Services | 3.77 | 52247 | 4.20 |
| Equity | Rubicon Research | Pharmaceuticals & Biotechnology | 3.68 | 27590 | 4.11 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.23 | 1298 | 3.60 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 3.03 | 1774 | 3.37 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 2.81 | 4152 | 3.14 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.56 | 21756 | 2.86 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 2.39 | 18111 | 2.66 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 2.25 | 5215 | 2.51 |
| Equity | Jupiter Life Lin | Healthcare Services | 2.23 | 74950 | 2.48 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.99 | 27457 | 2.22 |
| Equity | Global Health | Healthcare Services | 1.83 | 14551 | 2.04 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 1.35 | 13355 | 1.50 |
| Equity | Fortis Health. | Healthcare Services | 1.28 | 15160 | 1.43 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 1.23 | 5690 | 1.37 |
| Equity | Manipal Health | Healthcare Services | 0.96 | 18250 | 1.07 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.91 | 10285 | 1.01 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 0.90 | 20940 | 1.00 |
| Equity | ICICI Lombard | Insurance | 0.89 | 6118 | 0.99 |
| Equity | Lenskart Solut. | Retailing | 0.68 | 13501 | 0.75 |
| Equity | Sagility | IT - Services | 0.48 | 122624 | 0.53 |
| Equity | Dr Agarwal's Eye | Healthcare Services | 0.45 | 994 | 0.49 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
26,639.93
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham, Mr.Muralidharan Rajamani
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere
OTHER INFORMATION
Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Email:
Website:
